Class / Patent application number | Description | Number of patent applications / Date published |
604515000 | To or from the female reproductory tract | 32 |
20080228166 | Sonography guided embryo transfer for in vitro fertilization - The present provides novel systems and methods to facilitate embryo transfer, to maximize implantation rates and to improve pregnancy rates resulting from In Vitro fertilization. | 09-18-2008 |
20080243103 | Medical Device for Delivering a Bioactive and Method of Use Thereof - A device and method for delivering a bioactive to the uterine wall. In one embodiment, the device comprises a balloon having the bioactive present within the material of the balloon or on an outside surface of the balloon. Another embodiment provides a method comprising inserting the balloon into the uterus, inflating the balloon so that the outside surface of the balloon exerts pressure on uterine wall and delivering the bioactive to the uterine wall. | 10-02-2008 |
20090024108 | Methods and Devices for Delivery of Compositions to Conduits - The present invention comprises systems, methods and devices for the delivery of visualizable or treatment compositions or therapeutic agents comprising device elements for diagnosis and/or treatment of conduits. A delivery system comprising an introducer shaft having at least one exit port and at least one delivery catheter for placement of compositions into the conduit, such as a fallopian tube. | 01-22-2009 |
20090054868 | Uterine Therapy Device and Method - A method and system of providing therapy to a patient's uterus. The method includes the steps of inserting an access tool through a cervix and a cervical canal into the uterus; actively cooling the cervical canal; delivering vapor through the access tool lumen into the uterus; and condensing the vapor on tissue within the uterus. The system has an access tool with a lumen, the access tool being adapted to be inserted through a human cervical canal to place an opening of the lumen within a uterus when the access tool is inserted through the cervical canal; an active cooling mechanism adapted to cool the cervical canal, the active cooling mechanism having a coolant source; and a vapor delivery mechanism adapted to deliver condensable vapor through the access tool to the uterus, the condensable vapor being adapted to condense within the uterus. | 02-26-2009 |
20090054869 | Uterine Therapy Device and Method - A method and system of providing therapy to a patient's uterus. In some embodiments the method includes the steps of: inserting an access tool through a cervix and a cervical canal into the uterus; placing an expansion mechanism in contact with tissue within the uterus to move uterine tissue surfaces away from an opening in an access tool lumen; delivering vapor through the vapor delivery tool into the uterus; and condensing the vapor on tissue within the uterus. The system has an access tool adapted to be inserted through a human cervical canal to place an opening of an access tool lumen within a uterus when the access tool is inserted through the cervical canal; an expansion mechanism adapted to be advanced into the uterus to move uterine tissue surfaces away from the opening in the access tool lumen; and a vapor delivery mechanism adapted to deliver condensable vapor through the access tool to the uterus, the condensable vapor being adapted to condense within the uterus. | 02-26-2009 |
20090054870 | Uterine Therapy Device and Method - A method and system of providing therapy to a patient's uterus. The method include the following steps: inserting an access tool through a cervix and a cervical canal into the uterus; after inserting the access tool into the uterus, inserting a vapor delivery tool through an access tool lumen; delivering vapor through the vapor delivery tool into the uterus; and condensing the vapor on tissue within the uterus. The system has an access tool, the access tool being adapted to be inserted through a human cervical canal to place an opening of the access tool lumen within a uterus when the access tool is inserted through the cervical canal; and a vapor delivery mechanism, the vapor delivery mechanism having a vapor delivery tool and a vapor source, the vapor delivery tool being adapted to be inserted through the access tool to deliver condensable vapor from the vapor source to the uterus, the condensable vapor being adapted to condense within the uterus. | 02-26-2009 |
20090054871 | Uterine Therapy Device and Method - A method and system of providing therapy to a patient's uterus. The method includes the following steps: inserting an access tool through a cervix and a cervical canal into the uterus; after inserting the access tool into the uterus, creating a seal between an exterior surface of the access tool and an interior cervical os; providing an indication to a user that the seal has been created; delivering vapor through the access tool lumen into the uterus; and condensing the vapor on tissue within the uterus. The system has an access tool with a lumen, the access tool being adapted to be inserted through a human cervical canal to place an opening of the lumen within a uterus when the access tool is inserted through the cervical canal; a seal disposed at a distal region of the access tool and adapted to seal the access tool against an interior cervical os; a sealing indicator adapted to provide a user with an indication that the seal has sealed the access tool with the interior cervical os; and a vapor delivery mechanism adapted to deliver condensable vapor through the access tool to the uterus, the condensable vapor being adapted to condense within the uterus. | 02-26-2009 |
20090062770 | SEALING STOPPER AND ASSEMBLY COMPRISING SUCH A SEALING STOPPER - In order to enlarge the uterus, inter alia for diagnostic purposes, it is proposed to seal the cervix once a liquid, such as a gel, has been introduced, by means of a sealing stopper, so that liquid does not constantly have to be supplied to the uterus. The sealing stopper is preferably coupled to a gel feed device which may comprise a simple syringe-type structure. This system comprises a non-return valve, as a result of which a gel can only be displaced in the direction of the uterus. In order to ensure that the sealing stopper can be removed, return means, such as a piece of string, are attached thereto. | 03-05-2009 |
20090131909 | Device for the treatment of vaginal fungal infection - An absorbent article, e.g. tampons, sanitary napkins, panty liners and the like, and the process for their preparation in which a hydrophobic and/or cationactive layer is attached to a conventional absorbent layer, for the binding of microorganisms, specifically for treating or alleviating or prophylactically preventing vaginal fungal infections. | 05-21-2009 |
20090270835 | STEERABLE SONOHYSTEROGRAPHIC INJECTION CATHETER FOR UTERINE CANCER SENTINEL LYMPH NODE MAPPING - A steerable sonohysterographic injection catheter for identifying sentinel lymph nodes in uterine cancer patients includes a tubular shaft housing a needle extendible therefrom. The needle is preferably sized for intrauterine insertion and configured to deliver a fluid such as a contrast media to a tumor location. The catheter preferably includes a sealing device such as a selectively inflatable balloon disposed at a position along the outside of the catheter. The sealing device is configured for placement at an opening of a patient's cervix to prevent the leaking of the contrast media out of the uterus through the cervix. The distal end of the catheter is steerable so as to allow the tip of the needle to be positioned substantially near the tumor location. | 10-29-2009 |
20100087798 | SYSTEMS, METHODS AND DEVICES FOR USING A FLOWABLE MEDIUM FOR DISTENDING A HOLLOW ORGAN - Systems, methods, apparatus and devices for performing improved gynecologic and urologic procedures using a flowable distension media are disclosed. The system and devices provide simplified use and reduced risk of adverse events. Patient benefit is achieved through improved outcomes, reduced pain, especially peri-procedural pain, and reduced recovery times. The various embodiments enable procedures to be performed outside the hospital setting, such as in a doctor's office or clinic. | 04-08-2010 |
20100292671 | In Vivo Payload Delivery Apparatus and Method - The disclosed invention provides apparatus and methods for delivering a payload to a target location inside the body. A finger board is retained on the finger of a user, having a proximal end and a distal end. A payload holder is included at the distal end of the finger board for holding a payload during positioning and prior to delivery. An ejector is included for the purpose of ejecting the payload from the payload holder when actuated by a user. | 11-18-2010 |
20110066137 | APPLICATOR FOR APPLYING POWDER FORMULATIONS AND USES THEREOF - The present invention relates to applicators for applying powders to the vaginal mucosa. | 03-17-2011 |
20110087195 | TRANSMUCOSAL DRUG DELIVERY DEVICE AND METHOD INCLUDING MICRONEEDLES - Devices and methods for transmucosal drug delivery are provided. A device includes a housing configured for intralumenal deployment into a human or animal subject; a drug-dispensing portion which contains at least one drug; and a plurality of microneedles extending, or being extendable from, the housing, the plurality of microneedles being configured to disrupt at least one region of a mucosal barrier adjacent the housing at a selected time after being intralumenally deployed in the human or animal subject. The device is operable to dispense the drug from the housing to a region of the mucosal barrier disrupted by the plurality of microneedles. | 04-14-2011 |
20110270227 | METHOD AND APPARATUS FOR THE ENTERAL DISPENSATION OF LIQUID MEDICATIONS - An enteral dispenser and associated method of use is provided for enterally dispensing liquid medications. The enteral dispenser includes a barrel having a number of dosing gradations arranged upon its outer surface. The barrel receives a liquid medication that has been selected from a predefined group of liquid medications having a range of colors. A plunger is moveably disposed within the barrel, and a piston is coupled to a distal end of the plunger. The piston has a peripheral portion for selective alignment with respect to a desired one of the dosing gradations and is a color that is optically differentiable from each of the colors represented within the range of colors of the predefined group of liquid medications, such that an user may differentiate between the color of the a peripheral portion of the piston and the color of any selected liquid medication. | 11-03-2011 |
20110276030 | DELIVERY SYSTEM - A pharmaceutical delivery system that releases an active agent in a controlled manner for an extended period in the vaginal cavity to treat or cure ailments associated with the vaginal cavity or proximal areas. The delivery system includes an applicator which is composed of a high internal phase emulsion, allowing the delivery system to adhere to the mueosal surfaces of the body, primarily the lining of vaginal cavity. The delivery system can maintain the high internal phase emulsion at a temperature of 86° F. for at least one month, without decomposition or instability of the emulsion. | 11-10-2011 |
20120065619 | METHOD FOR LABIAL, VAGINAL, TRANSMUCOSAL AND TRANSDERMAL METERED DOSE DISPENSING - A method for using a dispensing apparatus having a fluid insert with an airless channel configured for labial, vaginal, transmucosal, and transdermal delivery of a therapeutic substance is disclosed. | 03-15-2012 |
20120071858 | Vaginal therapeutic device including copper metal and method of treating the vagina using the vaginal therapeutic device - A vaginal therapeutic device made of copper metal has a shape to fit in the vagina and utilizes the copper metal as an antimicrobial agent to therapeutically treat abnormal biological conditions in the vagina. | 03-22-2012 |
20130144264 | ABSORBABLE CRYSTALLINE COPOLYESTER-BASED BIOACTIVE HYDROFORMING LUMINAL LINER COMPOSITIONS - Bioactive, hydroforming luminal liner compositions are formed of high molecular weight crystalline, absorbable copolyesters dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and yeast-infected vaginal canals, esophagi, and arteries following angioplasty. | 06-06-2013 |
20130211384 | THERAPEUTIC AGENT, COMPOSITION INCLUDING SAID AGENT, IMPLANTABLE DEVICE AND PROCESS FOR THE TREATMENT OF CERVICAL CANCER AND/OR FOR THE PREVENTION OF THE FORMATION OF NEOPLASMS IN CORRESPONDENCE OF THE CERVIX IN A HUMAN FEMALE GENITAL SYSTEM - A medical composition including a chemotherapeutic medication or a targeted therapy medication is used in a human female patient for the treatment of a disease selected in the group comprising cervical cancer, cervical intraepithelial neoplasia (CIN), human papillomavirus (HPV) infection of the female genital system; the chemotherapeutic agent or targeted therapy medication is locally delivered directly to cervix of a female genital system by an implanted medical device including a stem to be implanted in the cervix. The stem has a drug carrying layer including the medical composition. A process for the treatment of the above diseases is also disclosed. | 08-15-2013 |
20130345678 | TREATMENT OF EXCESSIVE MENSTRUAL BLOOD LOSS BY FEMININE SANITARY PRODUCTS MEDICATED WITH ANTIFIBRINOLYTIC OR HEMOSTATIC AGENT - A method, medicated feminine sanitary products and compositions for reducing menstrual blood loss in a female are provided. The method comprises delivering an active agent to the uterine cavity by administering intravaginally to the female a therapeutically effective amount of the active agent on a medicated feminine sanitary product during menstrual bleeding, wherein the medicated feminine sanitary product is routinely utilized to absorb the menstrual flow, wherein the active agent is incorporated in the medicated feminine sanitary product as a pharmaceutically acceptable composition, the active agent is any of an antifibrinolytic and a hemostatic agent. | 12-26-2013 |
20140074067 | INTRAVAGINAL DEVICES FOR CONTROLLED DELIVERY OF LUBRICANTS - The present technology provides intravaginal devices designed to deliver lubricants to the vagina for a sustained period of time. The intravaginal devices include a first segment comprising an outer surface and a lumen containing a lubricant, wherein the first segment is configured to deliver the contents of the lumen to the outer surface, and the first segment comprises a polymer selected from the group consisting of a hydrophilic, semi-permeable elastomer and a hydrophobic elastomer. The lubricant may be an aqueous lubricant. The present technology further provides an intravaginal device including a solid first segment that includes a hydrophilic semi-permeable elastomer, an outer surface and an aqueous lubricant, wherein the first segment is configured to deliver the aqueous lubricant to the outer surface. | 03-13-2014 |
20140200553 | DEVICES AND METHODS FOR INTRALUMINAL RETENTION AND DRUG DELIVERY - Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject. | 07-17-2014 |
20140207112 | HYGIENE BOTTLE - A collapsible squeeze bottle suitable for use as a portable personal hygienic washing system provides vigorous cleansing action and can attain a compact configuration conducive to discreet concealment. The squeeze bottle includes non-collapsible top and bottom sections, and a central collapsible section having a plurality of pleats, a spout extending from the top section, and a perforated cap at the terminus of the spout. | 07-24-2014 |
20140296833 | INTRAUTERINE SYSTEM FOR USE IN MEDICAL TREATMENT - An intrauterine system is disclosed for use in the treatment of dysfunctional uterine bleeding; menorraghia; dysmenorrhoea; endometriosis; uterine fibroids; climacteric complaints; osteoporosis; and urogenital atrophy. The system is formed by a frame defining an interior space for receipt of a deposit of a therapeutically effective dose of a biologically active compound. The frame has an open structure allowing access to a substantial part of an outer surface of the deposit, and the deposit has a rate controlling structure that controls a rate of release of the compound within the uterus. One or more retention elements are provided on the frame for retaining the frame within the uterus of a female mammal. | 10-02-2014 |
20140296834 | DRUG DELIVERY DEVICE EMPLOYING WICKING RELEASE WINDOW - The present invention provides for a drug delivery device. The device can comprise at least one core with a first active pharmaceutical ingredient (API), coated with a first layer that is permeable or semi-permeable to the API, coated with a second layer that is impermeable to the API, and having a delivery window to allow passage of the API through the device and into body fluids or tissues. The device can also have a wicking material to modify the rate of transport of the API into the body fluid or tissues. | 10-02-2014 |
20140378948 | MEDICAMENT APPLICATOR - Apparatus and methods for inserting a medicament into a body cavity are described. The apparatus comprises an elongate tube with a plunger rod therein. The plunger rod has at least one projection which cooperatively interacts or engages with at least one discontinuity on the inside of the elongate tube so that proximal movement of the plunger rod with respect to the elongate tube expels the medicament into the body cavity. | 12-25-2014 |
20150065997 | TRANSMUCOSAL DRUG DELIVERY DEVICE AND METHOD INCLUDING CHEMICAL PERMEATION ENHANCERS - Devices and methods are provided for transmucosal drug delivery. The transmucosal drug delivery device may include a housing configured for intralumenal deployment, such as intravaginally, into a human or animal subject; a drug-dispensing portion which contains at least one drug, the drug-dispensing portion being configured to dispense the drug from the housing by positive displacement; and a permeability enhancer-dispensing portion configured to release or generate a permeability enhancing substance to disrupt at least one region of a mucosal barrier adjacent to the housing at a selected time while intralumenally deployed in the human or animal subject. The device may be operable to dispense the drug from the housing to a region of the mucosal barrier disrupted by the permeability enhancing substance. | 03-05-2015 |
20150105751 | MULTIPLE RESERVOIR DRUG DELIVERY DEVICE AND METHODS - Devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs. | 04-16-2015 |
20150141963 | DEVICE FOR INSTILLATION OF A CHEMICAL AGENT INTO THE ENDOMETRIAL CAVITY FOR PURPOSE OF GLOBAL ENDOMETRIAL ABLATION - A device for chemical endometrial ablation comprising an outer tube, a moveable cervical collar surrounding a portion of the outer tube and located near the distal end of the outer tube, an inner tube movable in a distal-proximal direction within the lumen of the outer tube, a porous and/or sponge-like material on the distal end of the inner tube within the lumen of the distal end of the outer tube having a size, shape, and expandability so that when the distal end of the inner tube within the distal end of the outer tube is moved in a distal direction in relation to the outer tube, the porous and/or sponge-like material expands to the approximate size of a uterus so as to contact the endometrium, a source of cauterizing agent, and means to cause the cauterizing agent to flow through the lumen of the inner tube onto the porous and/or sponge-like material. In operation, the cervical collar can be moved or advanced along the outer tube to the cervix and secured tightly around the external portion in order to prevent chemical cauterizing agent from entering the vagina. | 05-21-2015 |
20150359566 | THERAPEUTIC SUBSTANCE TRANSFER CATHETER AND METHOD - A cervical transfer catheter ( | 12-17-2015 |
20160001051 | METHOD OF DRUG DELIVERY FOR OVARIAN CANCER - A drug delivery device has been designed to directly deliver an agent to the ovaries through direct contact with the fallopian tubes. The device consists of three main components: a tubular inserter, a cylindrical chamber and a plunger. The device is a single-use applicator designed in a shape similar to a tampon to facilitate its insertion through the vagina and into the uterus. Positioning of the device centrally in the uterus is accomplished through the use of ultrasound. The chamber is inserted into the tubular inserter. Adjusting the length of the chamber inserted into the tubular inserter controls the amount of tubing released from the apertures in the tubular inserter. Ultrasound is used to ensure the proper placement of each tube at the entrance of each fallopian tube. The plunger is inserted into the chamber and adjustment of the plunger controls the amount of the agent released into the tubes. | 01-07-2016 |